EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ChatGPT in pharmacometrics? Potential opportunities and limitations

Michael E Cloesmeijer iD, Alexander Janssen, Sjoerd F Koopman iD, Marjon H Cnossen, Ron A A Mathôt, SYMPHONY consortium

British Journal of Clinical Pharmacology · 2024-01 · 90 (1) · 360-365

DOI: 10.1111/bcp.15895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 06.09.2023. Verfasst von Michael E Cloesmeijer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy - Clinical Pharmacology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Reproducibility of Results. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SYMPHONY, Netherlands Organization for Scientific Research, Boston Symphony Orchestra.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The potential of using ChatGPT in pharmacometrics was explored in this study, with a focus on developing a population pharmacokinetic (PK) model for standard half‐life factor VIII. Our results demonstrated that ChatGPT can be utilized to accurately obtain typical PK parameters from literature, generate a population PK model in R and develop an interactive Shiny application to visualize the results. ChatGPT's language generation capabilities enabled the development of R codes with minimal programming knowledge and helped to identify as well fix errors in the code. While ChatGPT presents several advantages, such as its ability to streamline the development process, its use in pharmacometrics also has limitations and challenges, including the accuracy and reliability of AI‐generated data, the lack of transparency and reproducibility regarding codes generated by ChatGPT. Overall, our study demonstrates the potential of using ChatGPT in pharmacometrics, but researchers must carefully evaluate its use for their specific needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reproducibility of ResultsHumansHalf-Life

Stichwörter der Autor:innen

haematologymodelling and simulationpharmacokineticspharmacometrics

Autor:innen und Institutionen

  • Department of Hospital Pharmacy - Clinical Pharmacology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Department of Pediatric Hematology and Oncology, Erasmus University Medical Center - Sophia Children's Hospital Rotterdam, Rotterdam, The Netherlands.

ORCID-Profile: Michael E Cloesmeijer, Sjoerd F Koopman

Förderung

  • SYMPHONY
  • Netherlands Organization for Scientific Research
  • Boston Symphony Orchestra

Zitieren

APA

Cloesmeijer, M. E., Janssen, A., Koopman, S. F., Cnossen, M. H., Mathôt, R. A. A., & SYMPHONY consortium (2024). ChatGPT in pharmacometrics? Potential opportunities and limitations. British Journal of Clinical Pharmacology, 90(1), 360-365. https://doi.org/10.1111/bcp.15895

Vancouver

Cloesmeijer ME, Janssen A, Koopman SF, Cnossen MH, Mathôt RAA, SYMPHONY consortium. ChatGPT in pharmacometrics? Potential opportunities and limitations. British Journal of Clinical Pharmacology. 2024;90(1):360-365. doi:10.1111/bcp.15895

BibTeX
@article{Cloesmeijer2024,
  author = {Cloesmeijer, Michael E and Janssen, Alexander and Koopman, Sjoerd F and Cnossen, Marjon H and Mathôt, Ron A A and SYMPHONY consortium, SYMPHONY consortium},
  title = {ChatGPT in pharmacometrics? Potential opportunities and limitations},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  volume = {90},
  number = {1},
  pages = {360--365},
  doi = {10.1111/bcp.15895}
}
Kostenlos starten →